Navitor Pharmaceuticals

📍 Cambridge, United States🗓 Founded 2010👥 10 employees💰 Last funded Dec 2017
Biotechnology Research🌐 navitorpharma.com
Website LinkedIn
Navitor Pharmaceuticals, Inc., is a biopharmaceutical company developing novel medicines by targeting cellular nutrient signaling pathways. The company’s proprietary drug discovery platform targets mTORC1, which responds to and integrates the cell’s response to nutrient availability and plays a key role in protein synthesis and cellular growth. Navitor’s therapeutics are designed to selectively modulate the cellular signals that are aberrant in disease processes caused by the dysregulation of mTORC1 activity to address a wide range of diseases, including metabolic, CNS, autoimmune and musculoskeletal diseases, as well as several rare disorders. The company is backed by leading financial and corporate investors, including Polaris Partners, Atlas Venture, J&J Innovation - JJDC, SR One, Brace Pharma Capital, Remeditex ventures, Sanofi Ventures and The Longevity Fund.
2
Total investors
0
Early stage
1
Mid stage
1
Late stage
2010
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
United States
1
Hong Kong SAR
1
Frequently asked questions
Who invested in Navitor Pharmaceuticals?
Navitor Pharmaceuticals has 2 investors on record on gritt.io, 1 mid-stage and 1 late-stage investors.
When did Navitor Pharmaceuticals last raise funding?
The most recent investment in Navitor Pharmaceuticals recorded on gritt.io was in December 2017.
When was Navitor Pharmaceuticals founded?
Navitor Pharmaceuticals was founded in 2010.
What industry is Navitor Pharmaceuticals in?
Navitor Pharmaceuticals operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Navitor Pharmaceuticals based?
Navitor Pharmaceuticals is headquartered in Cambridge, United States.